GlassScriptPhysician profile
Sandy Bui
NPI 1548577901
$1,182.36
in general payments reported to CMS, 2019-2025
17 companies · $605 in 2025
The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2023: $129 · 2024: $324 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.87 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $226.55 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $200.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $124.50 | 2019 | |
| Biogen, INC. | $112.00 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $88.95 | 2025 | |
| Coopersurgical, INC. | $64.28 | 2023-2025 | Paragard T 380a, Sos, Paragard T 380a |
| Shield Therapeutics INC | $61.83 | 2024-2025 | |
| Organon LLC | $52.36 | 2025 | Nexplanon |
| Hologic Sales and Service, LLC | $43.24 | 2025 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $43.11 | 2023-2024 | Ozempic, Rybelsus |
| Mayne Pharma Commercial LLC | $33.49 | 2025 | |
| Janssen Pharmaceuticals, INC | $30.02 | 2023 | Spravato |
| Guard Medical INC. | $27.67 | 2025 | Npseal |
| Exeltis, USA INC. | $24.51 | 2024 | Slynd |
| Agile Therapeutics, INC. | $21.04 | 2024 | Twirla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $14.77 | 2024 | Immunocap |
| Pfizer INC. | $13.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.